APAC sees fastest growth in global antibody discovery services market

Thanks to increasing pharmaceutical and biotechnology activities.

The Asia-Pacific region is expected to experience the fastest growth in antibody discovery services, with the global market projected to reach $3.54b by 2030, according to MarketsandMarkets.

The sector’s expansion is attributed to increasing pharmaceutical and biotechnology activities, particularly in China, India, South Korea, and Japan.

Meanwhile, a rise in research and development investments, the establishment of specialised antibody discovery facilities, and the availability of skilled scientific talent drive demand for these services.

“The lower cost of conducting research and clinical studies in several Asia Pacific countries also encouraged outsourcing by global pharmaceutical companies,” the report said.

The rising prevalence of chronic diseases and a growing pipeline of antibody-based therapeutics further fuel demand.

“Governments and private organisations in the region have increased funding for biologics research, creating opportunities for service providers to expand operations and partnerships,” it added.